Refine Your Search
Search Filters
Product family
Application
Search results for
Available results will be divided among three tabs below.
Options for narrowing the number of matches are available on the left.
Adding terms to the "Refine Your Search" box will apply more criteria to your current results. Making selections in the "Search Filters" box will further limit your results within a variety of categories, such as application, product type, kit size, etc.
Lenti-X™ SARS-CoV-2 Packaging Mix (No-Envelope Control)
Cat.# 632676
Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control) provides an extremely simple and consistent one-step method for producing high-titer lentivirus lacking an envelope protein. No additional transfection reagent is needed because Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control) consists of pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of lentiviral packaging plasmids. High-titer virus is produced by simply reconstituting this mixture with your lentiviral transfer vector of choice in sterile water and adding it to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Cat. # 632676 includes 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control) and is also sold as part of Lenti-X SARS-CoV-2 Packaging Single Shots.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (B.1.351 Spike, Full Length)
Cat.# 631292
Lenti-X SARS-CoV-2 Packaging Single Shots (B.1.351 Spike, Full Length) enable streamlined production of high-titer lentivirus pseudotyped with the spike protein from SARS-CoV-2 (B.1.351 variant) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (B.1.351 Spike, Full Length; Cat. # 631290), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (B.1.351 Spike, Truncated)
Cat.# 631293
Lenti-X SARS-CoV-2 Packaging Single Shots (B.1.351 Spike, Truncated) enable streamlined production of high-titer lentivirus pseudotyped with the spike protein from SARS-CoV-2 (B.1.351 variant) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (B.1.351 Spike, Truncated; Cat. # 631291), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (WT Spike, Full Length)
Cat.# 632668
Lenti-X SARS-CoV-2 Packaging Single Shots (WT Spike, Full Length) enable streamlined production of high-titer lentivirus pseudotyped with the spike protein from SARS-CoV-2 (Wuhan-Hu-1 isolate) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (WT Spike, Full Length; Cat. # 632672), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (D614G Spike, Full Length)
Cat.# 632669
Lenti-X SARS-CoV-2 Packaging Single Shots (D614G Spike, Full Length) enable streamlined production of high-titer lentivirus pseudotyped with the spike protein from SARS-CoV-2 (D614G mutant) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (D614G Spike, Full Length; Cat. # 632673), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (WT Spike, Truncated)
Cat.# 632670
Lenti-X SARS-CoV-2 Packaging Single Shots (WT Spike, Truncated) enable streamlined production of high-titer lentivirus pseudotyped with a truncated form of the spike protein from SARS-CoV-2 (Wuhan-Hu-1 isolate) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (WT Spike, Truncated; Cat. # 632674), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
Lenti-X™ SARS-CoV-2 Packaging Single Shots (D614G Spike, Truncated)
Cat.# 632671
Lenti-X SARS-CoV-2 Packaging Single Shots (D614G Spike, Truncated) enable streamlined production of high-titer lentivirus pseudotyped with a truncated form of the spike protein from SARS-CoV-2 (D614G mutant) by providing pre-aliquoted, lyophilized, single tubes of Xfect Transfection Reagent premixed with an optimized formulation of Lenti-X lentiviral packaging plasmids. Pseudovirus production simply involves reconstituting a tube of lyophilized packaging mix with a lentiviral transfer vector of choice in sterile water and adding the mixture to 293T cells (e.g., Lenti-X 293T Cells , Cat. # 632180) in a 10-cm dish. Each kit includes 12 tubes of Lenti-X SARS-CoV-2 Packaging Mix (D614G Spike, Truncated; Cat. # 632675), 6 tubes of Lenti-X SARS-CoV-2 Packaging Mix (No-Envelope Control; Cat. # 632676) for production of pseudoviral particles lacking an envelope protein, and the Lenti-X SARS-CoV-2 Vector Set (Cat. # 632677), which includes two self-inactivating lentiviral transfer vectors encoding ZsGreen1 and firefly luciferase, respectively, under the CMV promoter, to be used as reporters for viral transduction. For your convenience, the packaging mixes included in the kit are also sold separately.
